GeneReach Biotechnology Corp. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced total revenue was TWD 79.743 million compared to TWD 42.977 million a year ago. Operating income was TWD 22.596 million compared to TWD 1.290 million a year ago. Net income was TWD 18.165 million compared to TWD 3.622 million a year ago. Basic earnings per share was TWD 0.45 compared to TWD 0.11 a year ago. Diluted earnings per share was TWD 0.45 compared to TWD 0.06 a year ago. For the nine months, total revenue was TWD 242.956 million compared to TWD 131.855 million a year ago. Operating income was TWD 72.261 million compared to TWD 12.111 million a year ago. Net income was TWD 62.100 million compared to TWD 26.461 million a year ago. Basic earnings per share was TWD 1.64 compared to TWD 0.77 a year ago. Diluted earnings per share was TWD 1.57 compared to TWD 0.7 a year ago.